Loading...
XSHE300412
Market cap324mUSD
Dec 31, Last price  
4.62CNY
1D
-2.63%
1Q
12.91%
Jan 2017
-49.69%
IPO
83.38%
Name

Zhejiang Canaan Technology Ltd

Chart & Performance

D1W1MN
XSHE:300412 chart
P/E
—
P/S
2.17
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
1.28%
Rev. gr., 5y
12.59%
Revenues
1.05b
-5.11%
138,210,327152,084,830154,249,253183,810,026217,418,447301,792,829445,032,263578,756,391703,164,5461,007,249,1681,059,613,8691,103,431,0121,047,093,891
Net income
-23m
33,635,21536,214,95434,719,42642,762,13551,454,25257,040,40643,963,92933,632,54551,314,22667,905,49273,697,3750-23,433,467
CFO
-54m
L
21,190,07733,814,27920,846,95038,900,44139,955,51024,678,9080041,507,67555,469,48875,025,26268,616,352-53,646,586
Dividend
Jun 09, 20220.102 CNY/sh
Earnings
May 16, 2025

Profile

Zhejiang Canaan Technology Co., Ltd. engages in the development, manufacture, and marketing of pharmaceutical equipment in China. The company offers OSD products, such as dispensing, high shear mixer, roller compactor, fluid bed, mill, pelleting, lender, pharma lifter, tablet press, coater, capsule filling, washing machine, and pharma bin and series parts, as well as OEB equipment and isolators, R&D machines, APIs, packaging, water systems, extraction and reactor, and warehouse products. It primarily serves pharmaceutical industry. Zhejiang Canaan Technology Co., Ltd. was founded in 2000 and is based in Wenzhou, China.
URL
https://www.china-jianan.com/
IPO date
Dec 31, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,047,094
-5.11%
1,103,431
4.14%
Cost of revenue
952,341
1,011,199
Unusual Expense (Income)
NOPBT
94,753
92,232
NOPBT Margin
9.05%
8.36%
Operating Taxes
3,321
Tax Rate
3.50%
NOPAT
91,432
92,232
Net income
(23,433)
 
Dividends
(17,568)
Dividend yield
0.58%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
214,731
154,669
Long-term debt
203,556
129,465
Deferred revenue
7,653
8,211
Other long-term liabilities
1
Net debt
114,879
(106,301)
Cash flow
Cash from operating activities
(53,647)
68,616
CAPEX
(164,893)
Cash from investing activities
Cash from financing activities
130,076
FCF
(107,873)
77,372
Balance
Cash
295,125
390,435
Long term investments
8,283
2
Excess cash
251,054
335,264
Stockholders' equity
658,274
740,036
Invested Capital
1,219,200
1,004,013
ROIC
8.23%
9.40%
ROCE
6.43%
6.86%
EV
Common stock shares outstanding
468,669
497,757
Price
5.69
-5.79%
6.04
-58.24%
Market cap
2,666,729
-11.30%
3,006,450
-58.24%
EV
2,821,899
2,944,495
EBITDA
140,370
128,619
EV/EBITDA
20.10
22.89
Interest
7,303
5,829
Interest/NOPBT
7.71%
6.32%